CURI Long Call Strategy

CURI (CuriosityStream Inc.), in the Communication Services sector, (Broadcasting industry), listed on NASDAQ.

CuriosityStream Inc. operates as a factual content streaming service and media company. The company provides premium video programming services in various categories of factual entertainment, including science, history, society, nature, lifestyle, and technology through direct subscription video on-demand (SVoD) platforms accessible by internet connected devices, or indirectly via distribution partners who deliver CuriosityStream content via the distributor's platform or system; and through bundled content licenses for SVoD and linear offerings, partner bulk sales, brand partnerships, and content sales. It offers streaming content through devices, including televisions, set-top boxes, computers, streaming media players, game consoles, and mobile devices. As of December 31, 2021, it had approximately 23 million total paying subscribers, including direct subscribers, partner direct subscribers, and bundled MVPD subscribers. The company was founded in 2015 and is based in Silver Spring, Maryland.

CURI (CuriosityStream Inc.) trades in the Communication Services sector, specifically Broadcasting, with a market capitalization of approximately $174.9M, a beta of 1.85 versus the broader market, a 52-week range of 2.805-7.15, average daily share volume of 358K, a public-listing history dating back to 2020, approximately 45 full-time employees. These structural characteristics shape how CURI stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.85 indicates CURI has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. CURI pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a long call on CURI?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current CURI snapshot

As of May 15, 2026, spot at $2.46, ATM IV 73.50%, IV rank 17.60%, expected move 21.07%. The long call on CURI below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this long call structure on CURI specifically: CURI IV at 73.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a CURI long call, with a market-implied 1-standard-deviation move of approximately 21.07% (roughly $0.52 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CURI expiries trade a higher absolute premium for lower per-day decay. Position sizing on CURI should anchor to the underlying notional of $2.46 per share and to the trader's directional view on CURI stock.

CURI long call setup

The CURI long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CURI near $2.46, the first option leg uses a $2.46 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CURI chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CURI shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$2.46N/A

CURI long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

CURI long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on CURI. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on CURI

Long calls on CURI express a bullish thesis with defined risk; traders use them ahead of CURI catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

CURI thesis for this long call

The market-implied 1-standard-deviation range for CURI extends from approximately $1.94 on the downside to $2.98 on the upside. A CURI long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current CURI IV rank near 17.60% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CURI at 73.50%. As a Communication Services name, CURI options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CURI-specific events.

CURI long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CURI positions also carry Communication Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CURI alongside the broader basket even when CURI-specific fundamentals are unchanged. Long-premium structures like a long call on CURI are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current CURI chain quotes before placing a trade.

Frequently asked questions

What is a long call on CURI?
A long call on CURI is the long call strategy applied to CURI (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With CURI stock trading near $2.46, the strikes shown on this page are snapped to the nearest listed CURI chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are CURI long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the CURI long call priced from the end-of-day chain at a 30-day expiry (ATM IV 73.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a CURI long call?
The breakeven for the CURI long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CURI market-implied 1-standard-deviation expected move is approximately 21.07%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on CURI?
Long calls on CURI express a bullish thesis with defined risk; traders use them ahead of CURI catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current CURI implied volatility affect this long call?
CURI ATM IV is at 73.50% with IV rank near 17.60%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related CURI analysis